Alzheimer's Disease Drug Newly Approved

Leqembi to treat Alzheimer’s disease

Drug Name: Leqembi

Indications: To treat Alzheimer’s disease

Active Ingredient: Lecanemab-irmb

Company: Eisai Inc

Approval Date: 1/6/2023

More Details: https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761269Orig1s000lbl.pdf

Related

Alzheimer's Disease Brain Diagnostic Professional

Altoida: Pioneering Precision Neurology Diagnostics

Drug Practice Process Professional Research

Elevating Healthcare Conversations through AI-Enabled CI: KAI Conversations

Drug Practice Process Professional Research

Revolutionizing Pharmacovigilance with AI: DrugCard